See also this year's filing and all EDGAR filings for this company.
PDF Report 0001384101_2024_Veracyte_INC.pdf
Logs
info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 0.34034093478228106, 'aggregate_val': 444638000, 'exp_sum': 331735000, 'exp_to_value': {'LaborExpense': 0, 'CostOfGoodsAndServicesSold': 0, 'GeneralAndAdministrativeExpense': 86229000, 'GoodwillImpairmentLoss': 0, 'OperatingCostsAndExpenses': 0, 'DepreciationDepletionAndAmortization': 0, 'SellingAndMarketingExpense': 101490000, 'ResearchAndDevelopmentExpense': 57305000, 'remainder_Expenses': 86711000}} |
info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001384101, Veracyte INC
xvar | xval | |
---|---|---|
0 | IntangibleAssets | 791,577,000 |
1 | AssetsNonCurrent | 16,248,000 |
2 | AssetsCurrent | 285,621,000 |
3 | PropertyPlantAndEquipment | 20,584,000 |
4 | remainder_Assets | 876,000 |
5 | LongTermLiabilities | 8,311,000 |
6 | LiabilitiesCurrent | 61,975,000 |
7 | remainder_Liabilities | 518,000 |
8 | LaborExpense | 0 |
9 | CostOfGoodsAndServicesSold | 0 |
10 | GeneralAndAdministrativeExpense | 86,229,000 |
11 | GoodwillImpairmentLoss | 0 |
12 | OperatingCostsAndExpenses | 0 |
13 | DepreciationDepletionAndAmortization | 0 |
14 | SellingAndMarketingExpense | 101,490,000 |
15 | ResearchAndDevelopmentExpense | 57,305,000 |
16 | remainder_Expenses | 199,614,000 |
17 | remainder_Revenues | 361,051,000 |
18 | remainder_NetIncome | 9,183,000 |
19 | remainder_ComprehensiveNetIncome | 7,328,000 |
yvar | yval | |
---|---|---|
0 | Assets | 1,114,906,000 |
1 | Liabilities | 70,804,000 |
2 | Expenses | 444,638,000 |
3 | Revenues | 361,051,000 |
4 | StockholdersEquity | 1,044,102,000 |
5 | NetIncome | -74,404,000 |
6 | ComprehensiveNetIncome | -67,076,000 |
7 | BaseVar | 1,003,955,000 |
8 | EconomicCapitalRatio | 4.78 |